Immediate Impact
1 by Nobel laureates 12 from Science/Nature 52 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
Works of Carlos Bachier being referenced
A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS)
2020
Phase I Alexander study of AUTO3, the first CD19/22 dual targeting CAR T cell therapy, with pembrolizumab in patients with relapsed/refractory (r/r) DLBCL.
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Carlos Bachier | 620 | 440 | 370 | 86 | 1.4k | |
| Amparo Sempere | 378 | 399 | 266 | 64 | 1.4k | |
| DC Linch | 415 | 504 | 242 | 50 | 1.2k | |
| Hyeon‐Seok Eom | 836 | 515 | 416 | 132 | 1.7k | |
| Chi Young Ok | 569 | 664 | 232 | 85 | 1.5k | |
| Kaaren K. Reichard | 400 | 498 | 431 | 116 | 1.7k | |
| Judit Demeter | 407 | 415 | 262 | 107 | 1.5k | |
| Paul G. Schlegel | 586 | 480 | 473 | 56 | 1.7k | |
| Adrian Bloor | 470 | 431 | 303 | 63 | 1.4k | |
| Carlos Panizo | 440 | 281 | 266 | 91 | 1.4k | |
| Maurizio Musso | 354 | 672 | 268 | 66 | 1.3k |
All Works
Loading papers...